All News about Clearmind Medicine Inc
![](https://investorplace.com/wp-content/uploads/2023/02/bbby1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/04/19/sonnet_biotherapeutics_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2020/10/psychedelic-stocks-a-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/12/imedia_brands_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://investorplace.com/wp-content/uploads/2022/01/virgin-orbit-vorb-16.png)
![](https://investorplace.com/wp-content/uploads/2021/01/delisted-stocks-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/11/kalera_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2020/10/psychedelic-stocks-a-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/11/national_cinemedia_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
Clearmind Medicine Closes US$3.5 Million Public Offering
April 06, 2023
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/04/04/stocks_psychedelics_3_pexels.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/04/image46.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/04/bullfrog_ai_holdings_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/04/gold-image.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/04/analysis-4937349.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/03/20/psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/16/psychedelics_rd_drug_development_2.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://ml.globenewswire.com/media/130d7733-5794-4a6b-92bb-1eee23c524f3/small/picture3-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/03/13/image24.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/13/image22.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/03/03/10_psychedelics_ceos_2_shutterstock_1.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.